nervous system
• mice treated with the neurotoxin MPTP to induce Parkinson disease-like pathology show fewer TH neurons and fewer DAT-positive neurons indicating increased dopaminergic degeneration
• marker analysis indicates more highly activated necroptosis in dopaminergic neurons following MPTP treatment
|
• dopaminergic neuron loss in the substantia nigra par compacta is seen at 15 months of age, but not at 3 or 6 months
|
behavior/neurological
• mice exhibit more severe motor dysfunction after MPTP treatment, showing less mobile time with decreased motor activity in the open field test and shorter coordination time in the rotarod test
|
cellular
• mice treated with the neurotoxin MPTP to induce Parkinson disease-like pathology show fewer TH neurons and fewer DAT-positive neurons indicating increased dopaminergic degeneration
• marker analysis indicates more highly activated necroptosis in dopaminergic neurons following MPTP treatment
|
homeostasis/metabolism
• mice treated with the neurotoxin MPTP to induce Parkinson disease-like pathology show fewer TH neurons and fewer DAT-positive neurons indicating increased dopaminergic degeneration
• marker analysis indicates more highly activated necroptosis in dopaminergic neurons following MPTP treatment
|
immune system
• MPTP-treated mice show increased inflammatory cytokine TNF-alpha release in the brain
|